Clinical and serological predictors of suicide in schizophrenia and major mood disorders

Journal of Nervous and Mental Disease

Volumn 206, Issue 3, 2018, Pages 173-178

  Dickerson, Faith ^a   Origoni, Andrea ^a   Schweinfurth, Lucy A B ^a   Stallings, Cassie ^a   Savage, Christina L G ^a   Sweeney, Kevin ^a   Katsafanas, Emily ^a   Wilcox, Holly C ^b   Khushalani, Sunil ^a   Yolken, Robert ^c  

^a SHEPPARD PRATT HEALTH SYSTEM   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarkers; Mood disorders; Schizophrenia; Suicide; Viruses

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G; PROTOZOON ANTIBODY; VIRUS ANTIBODY;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BLOOD SAMPLING; CAUCASIAN; COHORT ANALYSIS; CYTOMEGALOVIRUS; DIVORCED PERSON; ENZYME IMMUNOASSAY; EPSTEIN BARR VIRUS; FEMALE; GENDER; HIGH RISK PATIENT; HUMAN; HUMAN ALPHAHERPESVIRUS 1; HUMAN HERPESVIRUS 6; MAJOR AFFECTIVE DISORDER; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NONHUMAN; PROSPECTIVE STUDY; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIA SPECTRUM DISORDER; SEPARATED PERSON; SEROLOGY; SUICIDE; TOXOPLASMA GONDII; ADOLESCENT; BLOOD; HERPESVIRIDAE; IMMUNOLOGY; MARRIAGE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PSYCHOLOGY; RISK FACTOR; SEX FACTOR; STATISTICS AND NUMERICAL DATA; TOXOPLASMA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIBODIES, PROTOZOAN; ANTIBODIES, VIRAL; BIPOLAR DISORDER; CYTOMEGALOVIRUS; DEPRESSIVE DISORDER, MAJOR; HERPESVIRIDAE; HUMANS; IMMUNOGLOBULIN G; MARITAL STATUS; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEX FACTORS; SUICIDE; TOXOPLASMA; YOUNG ADULT;

EID: 85047755362     PISSN: 00223018     EISSN: 1539736X     Source Type: Journal    
DOI: 10.1097/NMD.0000000000000772     Document Type: Article

References (34)

1. Arling TA, Yolken RH, Lapidus M, Langenberg P, Dickerson FB, Zimmerman SA, Balis T, Cabassa JA, Scrandis DA, Tonelli LH, Postolache TT (2009) Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders. J Nerv Ment Dis. 197:905–908.
2. Bani-Fatemi A, Polsinelli G, Kennedy JL, De Luca V (2013) Ethnicity and suicide attempt: Analysis in bipolar disorder and schizophrenia. BMC Psychiatry. 13:252.
3. Batterham PJ, Fairweather-Schmidt AK, Butterworth P, Calear AL, Mackinnon AJ, Christensen H (2014) Temporal effects of separation on suicidal thoughts and be-haviours. Soc Sci Med. 111:58–63.
4. Bhatia T, Franzos MA, Wood JA, Nimgaonkar VL, Deshpande SN (2004) Gender and procreation among patients with schizophrenia. Schizophr Res. 68:387–394.
5. Cavanagh JT, Carson AJ, Sharpe M, Lawrie SM (2003) Psychological autopsy studies of suicide: A systematic review. Psychol Med. 33:395–405.
6. Dickerson F, Lillehoj E, Stallings C, Wiley M, Origoni A, Vaughan C, Khushalani S, Sabunciyan S, Yolken R (2012) Antibodies to retroviruses in recent onset psychosis and multi-episode schizophrenia. Schizophr Res. 138:198–205.
7. Dickerson F, Stallings C, Origoni A, Katsafanas E, Schweinfurth LA, Savage CL, Yolken R (2014) Association between Cytomegalovirus antibody levels and cognitive functioning in non-elderly adults. PLoS One. 9:e95510.
8. Dickerson F, Wilcox HC, Adamos M, Katsafanas E, Khushalani S, Origoni A, Savage C, Schweinfurth L, Stallings C, Sweeney K, Yolken R (2017) Suicide attempts and markers of immune response in individuals with serious mental illness. J Psychiatr Res. 87:37–43.
9. Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Cole S, Krivogorsky B, Yolken RH (2004) Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder. Biol Psychiatry. 55:588–593.
10. Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Ruslanova I, Yolken RH (2003) Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia. Arch Gen Psychiatry. 60:466–472.
11. First M, Gibbon M, Spitzer RL, Williams JBW (1996) User's guide for the SCID-I, structured clinical interview for DSM IVAxis I disorders. New York, NY: Biometrics Research.
12. Han B, Kott PS, Hughes A, McKeon R, Blanco C, Compton WM (2016) Estimating the rates of deaths by suicide among adults who attempt suicide in the United States. J Psychiatr Res. 77:125–133.
13. Houenou J, d'Albis MA, Daban C, Hamdani N, Delavest M, Lepine JP, Vederine FE, Carde S, Lajnef M, Cabon C, Dickerson F, Yolken RH, Tamouza R, Poupon C, Leboyer M (2014) Cytomegalovirus seropositivity and serointensity are associated with hippocampal volume and verbal memory in schizophrenia and bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 48:142–148.
14. Khandaker GM, Stochl J, Zammit S, Lewis G, Jones PB (2014) Childhood Epstein-Barr Virus infection and subsequent risk of psychotic experiences in adolescence: A population-based prospective serological study. Schizophr Res. 158:19–24.
15. Mullins N, Perroud N, Uher R, Butler AW, Cohen-Woods S, Rivera M, Malki K, Euesden J, Power RA, Tansey KE, Jones L, Jones I, Craddock N, Owen MJ, Korszun A, Gill M, Mors O, Preisig M, Maier W, Rietschel M, Rice JP, Müller-Myhsok B, Binder EB, Lucae S, Ising M, Craig IW, Farmer AE, McGuffin P, Breen G, Lewis CM (2014) Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: A genome-wide association and polygenic scoring study. Am J Med Genet B Neuropsychiatr Genet. 165B:428–437.
16. Nimgaonkar VL, Yolken RH, Wang T, Chang CC, McClain L, McDade E, Snitz BE, Ganguli M (2016) Temporal cognitive decline associated with exposure to infectious agents in a population-based, aging cohort. Alzheimer Dis Assoc Disord. 30:216–222.
17. Nordentoft M, Mortensen PB, Pedersen CB (2011) Absolute risk of suicide after first hospital contact in mental disorder. Arch Gen Psychiatry. 68:1058–1064.
18. Okusaga O, Langenberg P, Sleemi A, Vaswani D, Giegling I, Hartmann AM, Konte B, Friedl M, Groer MW, Yolken RH, Rujescu D, Postolache TT (2011) Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia. Schizophr Res. 133:150–155.
19. Oquendo MA, Sullivan GM, Sudol K, Baca-Garcia E, Stanley BH, Sublette ME, Mann JJ (2014) Toward a biosignature for suicide. Am J Psychiatry. 171:1259–1277.
20. Ornaghi S, Davis JN, Gorres KL, Miller G, Paidas MJ, van den Pol AN (2016) Mood stabilizers inhibit Cytomegalovirus infection. Virology. 499:121–135.
21. Overall J, Gorham D (1962) The Brief Psychiatric Rating Scale. Psychol Rep. 10:799–812.
22. Palmer BA, Pankratz VS, Bostwick JM (2005) The lifetime risk of suicide in schizophrenia: A reexamination. Arch Gen Psychiatry. 62:247–253.
23. Pedersen MG, Mortensen PB, Norgaard-Pedersen B, Postolache TT (2012) Toxoplasma gondii infection and self-directed violence in mothers. Arch Gen Psychiatry. 69:1123–1130.
24. Popovic D, Benabarre A, Crespo JM, Goikolea JM, Gonzalez-Pinto A, Gutierrez-Rojas L, Montes JM, Vieta E (2014) Risk factors for suicide in schizophrenia: Systematic review and clinical recommendations. Acta Psychiatr Scand. 130: 418–426.
25. Prossin AR, Yolken RH, Kamali M, Heitzeg MM, Kaplow JB, Coryell WH, McInnis MG (2015) Cytomegalovirus antibody elevation in bipolar disorder: Relation to elevated mood states. Neural Plast. 2015:939780.
26. Randolph C, Tierney MC, Mohr E, Chase TN (1998) The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary clinical validity. J Clin Exp Neuropsychol. 20:310–319.
27. Ribeiro JD, Franklin JC, Fox KR, Bentley KH, Kleiman EM, Chang BP, Nock MK (2016) Self-injurious thoughts and behaviors as risk factors for future suicide ideation, attempts, and death: A meta-analysis of longitudinal studies. Psychol Med. 46:225–236.
28. Rockett IR, Hobbs GR, Wu D, Jia H, Nolte KB, Smith GS, Putnam SL, Caine ED (2015) Variable classification of drug-intoxication suicides across US states: A partial artifact of forensics? PLoS One. 10:e0135296.
29. Schaffer A, Isometsä ET, Azorin JM, Cassidy F, Goldstein T, Rihmer Z, Sinyor M, Tondo L, Moreno DH, Turecki G, Reis C, Kessing LV, Ha K, Weizman A, Beautrais A, Chou YH, Diazgranados N, Levitt AJ, Zarate CA Jr, Yatham L (2015a) A review of factors associated with greater likelihood of suicide attempts and suicide deaths in bipolar disorder: Part II of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. Aust N Z J Psychiatry. 49:1006–1020.
30. Schaffer A, Isometsä ET, Tondo L, Moreno DH, Sinyor M, Kessing LV, Turecki G, Weizman A, Azorin JM, Ha K, Reis C, Cassidy F, Goldstein T, Rihmer Z, Beautrais A, Chou YH, Diazgranados N, Levitt AJ, Zarate CA Jr, Yatham L (2015b) Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. Aust N Z J Psychiatry. 49:785–802.
31. Simanek AM, Cheng C, Yolken R, Uddin M, Galea S, Aiello AE (2014) Herpesvi-ruses, inflammatory markers and incident depression in a longitudinal study of Detroit residents. Psychoneuroendocrinology. 50:139–148.
32. Thomas P, Bhatia T, Gauba D, Wood J, Long C, Prasad K, Dickerson FB, Gur RE, Gur RC, Yolken RH, Nimgaonkar VL, Deshpande SN (2013) Exposure to herpes simplex virus, type 1 and reduced cognitive function. J Psychiatr Res. 47:1680–1685.
33. Welten SP, Redeker A, Toes RE, Arens R (2016) Viral persistence induces antibody inflation without altering antibody avidity. J Virol. 90:4402–4411.
34. Zalsman G, Hawton K, Wasserman D, van Heeringen K, Arensman E, Sarchiapone M, Carli V, Hoschl C, Barzilay R, Balazs J, Purebl G, Kahn JP, Saiz PA, Lipsicas CB, Bobes J, Cozman D, Hegerl U, Zohar J (2016) Suicide prevention strategies revisited: 10-Year systematic review. The lancet Psychiatry. 3:646–659.